TY - JOUR AU - Belfiore, A. AU - Frasca, F. AU - Pandini, G. AU - Sciacca, L. AU - Vigneri, R. PY - 2009 DA - 2009// TI - Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease JO - Endocr Rev VL - 30 UR - https://doi.org/10.1210/er.2008-0047 DO - 10.1210/er.2008-0047 ID - Belfiore2009 ER - TY - JOUR AU - Roith, D. PY - 2003 DA - 2003// TI - The insulin-like growth factor system JO - Exp Diabesity Res VL - 4 UR - https://doi.org/10.1155/EDR.2003.205 DO - 10.1155/EDR.2003.205 ID - Roith2003 ER - TY - JOUR AU - Khandwala, H. M. AU - McCutcheon, I. E. AU - Flyvbjerg, A. AU - Friend, K. E. PY - 2000 DA - 2000// TI - The effects of insulin-like growth factors on tumorigenesis and neoplastic growth JO - Endocr Rev VL - 21 UR - https://doi.org/10.1210/edrv.21.3.0399 DO - 10.1210/edrv.21.3.0399 ID - Khandwala2000 ER - TY - STD TI - Chiu L, Hsin I, Yang T, Sung W, Chi J, Chang J, Ko J, Sheu G. The ERK–ZEB1 pathway mediates epithelial–mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids. Oncogene. 2016. [Epub ahead of print]. ID - ref4 ER - TY - JOUR AU - Graham, T. R. AU - Zhau, H. E. AU - Odero-Marah, V. A. AU - Osunkoya, A. O. AU - Kimbro, K. S. AU - Tighiouart, M. AU - Liu, T. AU - Simons, J. W. AU - O’Regan, R. M. PY - 2008 DA - 2008// TI - Insulin-like growth factor-I–dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-2559 DO - 10.1158/0008-5472.CAN-07-2559 ID - Graham2008 ER - TY - STD TI - Motallebnezhad M, Aghebati-Maleki L, Jadidi-Niaragh F, Nickho H, Samadi-Kafil H, Shamsasenjan K, Yousefi M. The insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies. Tumor Biology. 2016;37(9):11711–21. ID - ref6 ER - TY - JOUR AU - Denduluri, S. K. AU - Idowu, O. AU - Wang, Z. AU - Liao, Z. AU - Yan, Z. AU - Mohammed, M. K. AU - Ye, J. AU - Wei, Q. AU - Wang, J. AU - Zhao, L. PY - 2015 DA - 2015// TI - Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance JO - Genes & Diseases VL - 2 UR - https://doi.org/10.1016/j.gendis.2014.10.004 DO - 10.1016/j.gendis.2014.10.004 ID - Denduluri2015 ER - TY - JOUR AU - Zhao, H. AU - Desai, V. AU - Wang, J. AU - Epstein, D. M. AU - Miglarese, M. AU - Buck, E. PY - 2012 DA - 2012// TI - Epithelial–mesenchymal transition predicts sensitivity to the dual IGF-1R/IR inhibitor OSI-906 in hepatocellular carcinoma cell lines JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0327 DO - 10.1158/1535-7163.MCT-11-0327 ID - Zhao2012 ER - TY - JOUR AU - Wang, R. AU - Li, H. AU - Guo, X. AU - Wang, Z. AU - Liang, S. AU - Dang, C. PY - 2016 DA - 2016// TI - IGF-I induces epithelial-to-mesenchymal transition via the IGF-IR‐Src‐MicroRNA-30a‐E-cadherin pathway in nasopharyngeal carcinoma cells JO - Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics VL - 24 UR - https://doi.org/10.3727/096504016X14648701447931 DO - 10.3727/096504016X14648701447931 ID - Wang2016 ER - TY - JOUR AU - Wang, Y. H. AU - Han, X. D. AU - Qiu, Y. AU - Xiong, J. AU - Yu, Y. AU - Wang, B. AU - Zhu, Z. Z. AU - Qian, B. P. AU - Chen, Y. X. AU - Wang, S. F. PY - 2012 DA - 2012// TI - Increased expression of insulin‐like growth factor‐1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma JO - J Surg Oncol VL - 105 UR - https://doi.org/10.1002/jso.22077 DO - 10.1002/jso.22077 ID - Wang2012 ER - TY - JOUR AU - Dale, O. T. AU - Aleksic, T. AU - Shah, K. A. AU - Han, C. AU - Mehanna, H. AU - Rapozo, D. C. AU - Sheard, J. D. AU - Goodyear, P. AU - Upile, N. S. AU - Robinson, M. PY - 2015 DA - 2015// TI - IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer JO - Carcinogenesis VL - 36 UR - https://doi.org/10.1093/carcin/bgv053 DO - 10.1093/carcin/bgv053 ID - Dale2015 ER - TY - JOUR AU - Numata, K. AU - Oshima, T. AU - Sakamaki, K. AU - Yoshihara, K. AU - Aoyama, T. AU - Hayashi, T. AU - Yamada, T. AU - Sato, T. AU - Cho, H. AU - Shiozawa, M. PY - 2016 DA - 2016// TI - Clinical significance of IGF1R gene expression in patients with stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1 JO - J Cancer Res Clin Oncol VL - 142 UR - https://doi.org/10.1007/s00432-015-2039-6 DO - 10.1007/s00432-015-2039-6 ID - Numata2016 ER - TY - JOUR AU - Heskamp, S. AU - Boerman, O. C. AU - Molkenboer-Kuenen, J. D. AU - Wauters, C. A. AU - Strobbe, L. J. AU - Mandigers, C. M. AU - Bult, P. AU - Oyen, W. J. AU - Graaf, W. T. AU - Laarhoven, H. W. PY - 2015 DA - 2015// TI - Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0117745 DO - 10.1371/journal.pone.0117745 ID - Heskamp2015 ER - TY - JOUR AU - Yeo, C. D. AU - Park, K. H. AU - Park, C. K. AU - Lee, S. H. AU - Kim, S. J. AU - Yoon, H. K. AU - Lee, Y. S. AU - Lee, E. J. AU - Lee, K. Y. AU - Kim, T. -. J. PY - 2015 DA - 2015// TI - Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations JO - Lung Cancer VL - 87 UR - https://doi.org/10.1016/j.lungcan.2015.01.004 DO - 10.1016/j.lungcan.2015.01.004 ID - Yeo2015 ER - TY - JOUR AU - Robertson, J. F. AU - Ferrero, J. -. M. AU - Bourgeois, H. AU - Kennecke, H. AU - Boer, R. H. AU - Jacot, W. AU - McGreivy, J. AU - Suzuki, S. AU - Zhu, M. AU - McCaffery, I. PY - 2013 DA - 2013// TI - Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70026-3 DO - 10.1016/S1470-2045(13)70026-3 ID - Robertson2013 ER - TY - JOUR AU - Guha, M. PY - 2013 DA - 2013// TI - Anticancer IGF1R classes take more knocks JO - Nat Rev Drug Discov VL - 12 UR - https://doi.org/10.1038/nrd3992 DO - 10.1038/nrd3992 ID - Guha2013 ER - TY - JOUR AU - Sclafani, F. AU - Kim, T. Y. AU - Cunningham, D. AU - Kim, T. W. AU - Tabernero, J. AU - Schmoll, H. J. AU - Roh, J. K. AU - Kim, S. Y. AU - Park, Y. S. AU - Guren, T. K. PY - 2015 DA - 2015// TI - A randomized phase II/III study of dalotuzumab in combination with cetuximab and irinotecan in chemorefractory, KRAS wild-type, metastatic colorectal cancer JO - J Natl Cancer Inst VL - 107 UR - https://doi.org/10.1093/jnci/djv258 DO - 10.1093/jnci/djv258 ID - Sclafani2015 ER - TY - JOUR AU - Pollak, M. PY - 2012 DA - 2012// TI - The insulin and insulin-like growth factor receptor family in neoplasia: an update JO - Nat Rev Cancer VL - 12 ID - Pollak2012 ER - TY - JOUR AU - Samani, A. A. AU - Yakar, S. AU - LeRoith, D. AU - Brodt, P. PY - 2007 DA - 2007// TI - The role of the IGF system in cancer growth and metastasis: overview and recent insights JO - Endocr Rev VL - 28 UR - https://doi.org/10.1210/er.2006-0001 DO - 10.1210/er.2006-0001 ID - Samani2007 ER - TY - JOUR AU - Foulstone, E. AU - Prince, S. AU - Zaccheo, O. AU - Burns, J. AU - Harper, J. AU - Jacobs, C. AU - Church, D. AU - Hassan, A. PY - 2005 DA - 2005// TI - Insulin‐like growth factor ligands, receptors, and binding proteins in cancer JO - J Pathol VL - 205 UR - https://doi.org/10.1002/path.1712 DO - 10.1002/path.1712 ID - Foulstone2005 ER - TY - JOUR AU - Ullrich, A. AU - Gray, A. AU - Tam, A. W. AU - Yang-Feng, T. AU - Tsubokawa, M. AU - Collins, C. AU - Henzel, W. AU - Bon, T. AU - Kathuria, S. AU - Chen, E. PY - 1986 DA - 1986// TI - Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity JO - EMBO J VL - 5 ID - Ullrich1986 ER - TY - JOUR AU - LeRoith, D. AU - Werner, H. AU - Beitner-Johnson, D. AU - Roberts, A. T. PY - 1995 DA - 1995// TI - Molecular and cellular aspects of the insulin-like growth factor I receptor JO - Endocr Rev VL - 16 UR - https://doi.org/10.1210/edrv-16-2-143 DO - 10.1210/edrv-16-2-143 ID - LeRoith1995 ER - TY - JOUR AU - Braulke, T. PY - 1998 DA - 1998// TI - Type-2 IGF receptor: a multi-ligand binding protein JO - Horm Metab Res VL - 31 ID - Braulke1998 ER - TY - JOUR AU - Byrd, J. C. AU - Devi, G. R. AU - Souza, A. T. AU - Jirtle, R. L. AU - MacDonald, R. G. PY - 1999 DA - 1999// TI - Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.34.24408 DO - 10.1074/jbc.274.34.24408 ID - Byrd1999 ER - TY - JOUR AU - Sciacca, L. AU - Costantino, A. AU - Pandini, G. AU - Mineo, R. AU - Frasca, F. AU - Scalia, P. AU - Sbraccia, P. AU - Goldfine, I. D. AU - Vigneri, R. AU - Belfiore, A. PY - 1999 DA - 1999// TI - Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1202600 DO - 10.1038/sj.onc.1202600 ID - Sciacca1999 ER - TY - JOUR AU - Frasca, F. AU - Pandini, G. AU - Scalia, P. AU - Sciacca, L. AU - Mineo, R. AU - Costantino, A. AU - Goldfine, I. AU - Belfiore, A. AU - Vigneri, R. PY - 1999 DA - 1999// TI - Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells JO - Mol Cell Biol VL - 19 UR - https://doi.org/10.1128/MCB.19.5.3278 DO - 10.1128/MCB.19.5.3278 ID - Frasca1999 ER - TY - JOUR AU - Duan, C. AU - Ren, H. AU - Gao, S. PY - 2010 DA - 2010// TI - Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation JO - Gen Comp Endocrinol VL - 167 UR - https://doi.org/10.1016/j.ygcen.2010.04.009 DO - 10.1016/j.ygcen.2010.04.009 ID - Duan2010 ER - TY - JOUR AU - Jones, J. I. AU - Clemmons, D. R. PY - 1995 DA - 1995// TI - Insulin-like growth factors and their binding proteins: biological actions* JO - Endocr Rev VL - 16 ID - Jones1995 ER - TY - JOUR AU - Hwa, V. AU - Oh, Y. AU - Rosenfeld, R. G. PY - 1999 DA - 1999// TI - The insulin-like growth factor-binding protein (IGFBP) superfamily 1 JO - Endocr Rev VL - 20 ID - Hwa1999 ER - TY - JOUR AU - Doepfner, K. AU - Spertini, O. AU - Arcaro, A. PY - 2007 DA - 2007// TI - Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway JO - Leukemia VL - 21 UR - https://doi.org/10.1038/sj.leu.2404813 DO - 10.1038/sj.leu.2404813 ID - Doepfner2007 ER - TY - JOUR AU - Kaleko, M. AU - Rutter, W. J. AU - Miller, A. D. PY - 1990 DA - 1990// TI - Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation JO - Mol Cell Biol VL - 10 UR - https://doi.org/10.1128/MCB.10.2.464 DO - 10.1128/MCB.10.2.464 ID - Kaleko1990 ER - TY - JOUR AU - Stiles, C. AU - Capone, G. T. AU - Scher, C. AU - Antoniades, H. AU - Wyk, J. AU - Pledger, W. PY - 1979 DA - 1979// TI - Dual control of cell growth by somatomedins and platelet-derived growth factor JO - Proc Natl Acad Sci VL - 76 UR - https://doi.org/10.1073/pnas.76.3.1279 DO - 10.1073/pnas.76.3.1279 ID - Stiles1979 ER - TY - JOUR AU - Hartog, H. AU - Horlings, H. M. AU - Vegt, B. AU - Kreike, B. AU - Ajouaou, A. AU - Vijver, M. J. AU - Boezen, H. M. AU - Bock, G. H. AU - Graaf, W. T. AU - Wesseling, J. PY - 2011 DA - 2011// TI - Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma JO - Breast Cancer Res Treat VL - 129 UR - https://doi.org/10.1007/s10549-010-1256-6 DO - 10.1007/s10549-010-1256-6 ID - Hartog2011 ER - TY - JOUR AU - Cappuzzo, F. AU - Toschi, L. AU - Tallini, G. AU - Ceresoli, G. AU - Domenichini, I. AU - Bartolini, S. AU - Finocchiaro, G. AU - Magrini, E. AU - Metro, G. AU - Cancellieri, A. PY - 2006 DA - 2006// TI - Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdl077 DO - 10.1093/annonc/mdl077 ID - Cappuzzo2006 ER - TY - JOUR AU - Park, E. AU - Park, S. Y. AU - Kim, H. AU - Sun, P. -. L. AU - Jin, Y. AU - Cho, S. K. AU - Kim, K. AU - Lee, C. -. T. AU - Chung, J. -. H. PY - 2015 DA - 2015// TI - Membranous insulin-like growth factor-1 receptor (IGF1R) expression is predictive of poor prognosis in patients with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma JO - J Pathol Transl Med VL - 49 UR - https://doi.org/10.4132/jptm.2015.07.10 DO - 10.4132/jptm.2015.07.10 ID - Park2015 ER - TY - JOUR AU - Lorenzatti, G. AU - Huang, W. AU - Pal, A. AU - Cabanillas, A. M. AU - Kleer, C. G. PY - 2011 DA - 2011// TI - CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer JO - J Cell Sci VL - 124 UR - https://doi.org/10.1242/jcs.084194 DO - 10.1242/jcs.084194 ID - Lorenzatti2011 ER - TY - JOUR AU - Li, H. AU - Xu, L. AU - Li, C. AU - Zhao, L. AU - Ma, Y. AU - Zheng, H. AU - Li, Z. AU - Zhang, Y. AU - Wang, R. AU - Liu, Y. PY - 2014 DA - 2014// TI - Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-1 DO - 10.1186/1476-4598-13-1 ID - Li2014 ER - TY - JOUR AU - Li, H. AU - Xu, L. AU - Zhao, L. AU - Ma, Y. AU - Zhu, Z. AU - Liu, Y. AU - Qu, X. PY - 2015 DA - 2015// TI - Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3β and ZEB2 in the BGC-823 gastric cancer cell line JO - Oncol Lett VL - 9 ID - Li2015 ER - TY - JOUR AU - Zhou, J. AU - Wang, J. AU - Zeng, Y. AU - Zhang, X. AU - Hu, Q. AU - Zheng, J. AU - Chen, B. AU - Xie, B. AU - Zhang, W. -. M. PY - 2015 DA - 2015// TI - Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer JO - Oncotarget VL - 6 ID - Zhou2015 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Cufí, S. AU - Oliveras-Ferraros, C. AU - Torres-Garcia, V. Z. AU - Corominas-Faja, B. AU - Cuyàs, E. AU - Bonavia, R. AU - Visa, J. AU - Martin-Castillo, B. AU - Barrajón-Catalán, E. PY - 2013 DA - 2013// TI - IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations JO - Sci Rep VL - 3 UR - https://doi.org/10.1038/srep02560 DO - 10.1038/srep02560 ID - Vazquez-Martin2013 ER - TY - JOUR AU - Zhang, Z. AU - Wang, J. AU - Ji, D. AU - Wang, C. AU - Liu, R. AU - Wu, Z. AU - Liu, L. AU - Zhu, D. AU - Chang, J. AU - Geng, R. PY - 2014 DA - 2014// TI - Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-3396 DO - 10.1158/1078-0432.CCR-13-3396 ID - Zhang2014 ER - TY - JOUR AU - Muranen, T. E. AU - Selfors, L. AU - Worster, D. AU - Iwanicki, M. AU - Song, L. AU - Morlaes, F. AU - Mills, G. B. AU - Brugge, J. S. PY - 2012 DA - 2012// TI - Inhibition of PI3K/mTOR leads to adaptive resistance in extracellular matrix attached cancer cells JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/1538-7445.AM2012-4836 DO - 10.1158/1538-7445.AM2012-4836 ID - Muranen2012 ER - TY - JOUR AU - Thiery, J. P. AU - Acloque, H. AU - Huang, R. Y. AU - Nieto, M. A. PY - 2009 DA - 2009// TI - Epithelial-mesenchymal transitions in development and disease JO - Cell VL - 139 UR - https://doi.org/10.1016/j.cell.2009.11.007 DO - 10.1016/j.cell.2009.11.007 ID - Thiery2009 ER - TY - JOUR AU - Mitra, A. AU - Mishra, L. AU - Li, S. PY - 2015 DA - 2015// TI - EMT, CTCs and CSCs in tumor relapse and drug-resistance JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4037 DO - 10.18632/oncotarget.4037 ID - Mitra2015 ER - TY - JOUR AU - Kalluri, R. AU - Neilson, E. G. PY - 2003 DA - 2003// TI - Epithelial-mesenchymal transition and its implications for fibrosis JO - J Clin Invest VL - 112 UR - https://doi.org/10.1172/JCI200320530 DO - 10.1172/JCI200320530 ID - Kalluri2003 ER - TY - JOUR AU - Kalluri, R. AU - Weinberg, R. A. PY - 2009 DA - 2009// TI - The basics of epithelial-mesenchymal transition JO - J Clin Invest VL - 119 UR - https://doi.org/10.1172/JCI39104 DO - 10.1172/JCI39104 ID - Kalluri2009 ER - TY - JOUR AU - Zeisberg, M. AU - Neilson, E. G. PY - 2009 DA - 2009// TI - Biomarkers for epithelial-mesenchymal transitions JO - J Clin Invest VL - 119 UR - https://doi.org/10.1172/JCI36183 DO - 10.1172/JCI36183 ID - Zeisberg2009 ER - TY - JOUR AU - Thiery, J. P. PY - 2002 DA - 2002// TI - Epithelial–mesenchymal transitions in tumour progression JO - Nat Rev Cancer VL - 2 UR - https://doi.org/10.1038/nrc822 DO - 10.1038/nrc822 ID - Thiery2002 ER - TY - JOUR AU - Singh, A. AU - Settleman, J. PY - 2010 DA - 2010// TI - EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.215 DO - 10.1038/onc.2010.215 ID - Singh2010 ER - TY - JOUR AU - Radisky, D. C. AU - LaBarge, M. A. PY - 2008 DA - 2008// TI - Epithelial-mesenchymal transition and the stem cell phenotype JO - Cell Stem Cell VL - 2 UR - https://doi.org/10.1016/j.stem.2008.05.007 DO - 10.1016/j.stem.2008.05.007 ID - Radisky2008 ER - TY - JOUR AU - Franco, D. L. AU - Mainez, J. AU - Vega, S. AU - Sancho, P. AU - Murillo, M. M. AU - Frutos, C. A. AU - Castillo, G. AU - López-Blau, C. AU - Fabregat, I. AU - Nieto, M. A. PY - 2010 DA - 2010// TI - Snail1 suppresses TGF-β-induced apoptosis and is sufficient to trigger EMT in hepatocytes JO - J Cell Sci VL - 123 UR - https://doi.org/10.1242/jcs.068692 DO - 10.1242/jcs.068692 ID - Franco2010 ER - TY - JOUR AU - Nieto, M. A. AU - Huang, R. Y. -. J. AU - Jackson, R. A. AU - Thiery, J. P. PY - 2016 DA - 2016// TI - EMT: 2016 JO - Cell VL - 166 UR - https://doi.org/10.1016/j.cell.2016.06.028 DO - 10.1016/j.cell.2016.06.028 ID - Nieto2016 ER - TY - JOUR AU - Wijnhoven, B. AU - Dinjens, W. AU - Pignatelli, M. PY - 2000 DA - 2000// TI - E‐cadherin—catenin cell—cell adhesion complex and human cancer JO - Br J Surg VL - 87 UR - https://doi.org/10.1046/j.1365-2168.2000.01513.x DO - 10.1046/j.1365-2168.2000.01513.x ID - Wijnhoven2000 ER - TY - JOUR AU - Goswami, M. T. AU - Reka, A. K. AU - Kurapati, H. AU - Kaza, V. AU - Chen, J. AU - Standiford, T. J. AU - Keshamouni, V. G. PY - 2016 DA - 2016// TI - Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.258 DO - 10.1038/onc.2015.258 ID - Goswami2016 ER - TY - JOUR AU - Ghahhari, N. M. AU - Babashah, S. PY - 2015 DA - 2015// TI - Interplay between microRNAs and WNT/β-catenin signalling pathway regulates epithelial–mesenchymal transition in cancer JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.04.021 DO - 10.1016/j.ejca.2015.04.021 ID - Ghahhari2015 ER - TY - JOUR AU - Bui, Q. AU - Kang, K. PY - 2016 DA - 2016// TI - Abstract P1-05-06: essential role of notch-4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/1538-7445.SABCS15-P1-05-06 DO - 10.1158/1538-7445.SABCS15-P1-05-06 ID - Bui2016 ER - TY - JOUR AU - Stewart, T. A. AU - Azimi, I. AU - Davis, F. M. AU - Thompson, E. W. AU - Brooks, A. J. AU - Roberts-Thomson, S. J. AU - Monteith, G. R. PY - 2015 DA - 2015// TI - Abstract P2-07-05: a potential role for Janus protein tyrosine kinases in the regulation of epithelial-mesenchymal transition in a model of epidermal growth factor induced breast cancer epithelial-mesenchymal transition JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/1538-7445.SABCS14-P2-07-05 DO - 10.1158/1538-7445.SABCS14-P2-07-05 ID - Stewart2015 ER - TY - JOUR AU - Peinado, H. AU - Olmeda, D. AU - Cano, A. PY - 2007 DA - 2007// TI - Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? JO - Nat Rev Cancer VL - 7 UR - https://doi.org/10.1038/nrc2131 DO - 10.1038/nrc2131 ID - Peinado2007 ER - TY - JOUR AU - Wang, Y. AU - Shi, J. AU - Chai, K. AU - Ying, X. AU - P Zhou, B. PY - 2013 DA - 2013// TI - The role of Snail in EMT and tumorigenesis JO - Curr Cancer Drug Targets VL - 13 UR - https://doi.org/10.2174/15680096113136660102 DO - 10.2174/15680096113136660102 ID - Wang2013 ER - TY - JOUR AU - Cano, A. AU - Pérez-Moreno, M. A. AU - Rodrigo, I. AU - Locascio, A. AU - Blanco, M. J. AU - Barrio, M. G. AU - Portillo, F. AU - Nieto, M. A. PY - 2000 DA - 2000// TI - The transcription factor snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression JO - Nat Cell Biol VL - 2 UR - https://doi.org/10.1038/35000025 DO - 10.1038/35000025 ID - Cano2000 ER - TY - JOUR AU - Tran, D. D. AU - Corsa, C. A. S. AU - Biswas, H. AU - Aft, R. L. AU - Longmore, G. D. PY - 2011 DA - 2011// TI - Temporal and spatial cooperation of Snail1 and Twist1 during epithelial–mesenchymal transition predicts for human breast cancer recurrence JO - Mol Cancer Res VL - 9 UR - https://doi.org/10.1158/1541-7786.MCR-11-0371 DO - 10.1158/1541-7786.MCR-11-0371 ID - Tran2011 ER - TY - JOUR AU - Sobrado, V. R. AU - Moreno-Bueno, G. AU - Cubillo, E. AU - Holt, L. J. AU - Nieto, M. A. AU - Portillo, F. AU - Cano, A. PY - 2009 DA - 2009// TI - The class I bHLH factors E2-2A and E2-2B regulate EMT JO - J Cell Sci VL - 122 UR - https://doi.org/10.1242/jcs.028241 DO - 10.1242/jcs.028241 ID - Sobrado2009 ER - TY - JOUR AU - Hollier, B. G. AU - Tinnirello, A. A. AU - Werden, S. J. AU - Evans, K. W. AU - Taube, J. H. AU - Sarkar, T. R. AU - Sphyris, N. AU - Shariati, M. AU - Kumar, S. V. AU - Battula, V. L. PY - 2013 DA - 2013// TI - FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-2962 DO - 10.1158/0008-5472.CAN-12-2962 ID - Hollier2013 ER - TY - JOUR AU - Massagué, J. PY - 2012 DA - 2012// TI - TGFβ signalling in context JO - Nat Rev Mol Cell Biol VL - 13 UR - https://doi.org/10.1038/nrm3434 DO - 10.1038/nrm3434 ID - Massagué2012 ER - TY - JOUR AU - Tsubaki, M. AU - Komai, M. AU - Fujimoto, S. -. i. AU - Itoh, T. AU - Imano, M. AU - Sakamoto, K. AU - Shimaoka, H. AU - Takeda, T. AU - Ogawa, N. AU - Mashimo, K. PY - 2013 DA - 2013// TI - Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines JO - J Exp Clin Cancer Res VL - 32 UR - https://doi.org/10.1186/1756-9966-32-62 DO - 10.1186/1756-9966-32-62 ID - Tsubaki2013 ER - TY - JOUR AU - Li, C. -. W. AU - Xia, W. AU - Huo, L. AU - Lim, S. -. O. AU - Wu, Y. AU - Hsu, J. L. AU - Chao, C. -. H. AU - Yamaguchi, H. AU - Yang, N. -. K. AU - Ding, Q. PY - 2012 DA - 2012// TI - Epithelial–mesenchymal transition induced by TNF-α requires NF-κB–mediated transcriptional upregulation of Twist1 JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3123 DO - 10.1158/0008-5472.CAN-11-3123 ID - Li2012 ER - TY - JOUR AU - Grego-Bessa, J. AU - Díez, J. PY - 2004 DA - 2004// TI - Pompa JLdl: Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw JO - Cell Cycle VL - 3 UR - https://doi.org/10.4161/cc.3.6.949 DO - 10.4161/cc.3.6.949 ID - Grego-Bessa2004 ER - TY - JOUR AU - Stemmer, V. AU - Craene, B. AU - Berx, G. AU - Behrens, J. PY - 2008 DA - 2008// TI - Snail promotes Wnt target gene expression and interacts with β-catenin JO - Oncogene VL - 27 UR - https://doi.org/10.1038/onc.2008.140 DO - 10.1038/onc.2008.140 ID - Stemmer2008 ER - TY - JOUR AU - Braun, J. AU - Hoang-Vu, C. AU - Dralle, H. AU - Hüttelmaier, S. PY - 2010 DA - 2010// TI - Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.169 DO - 10.1038/onc.2010.169 ID - Braun2010 ER - TY - JOUR AU - Chan, J. M. AU - Stampfer, M. J. AU - Giovannucci, E. AU - Gann, P. H. AU - Ma, J. AU - Wilkinson, P. AU - Hennekens, C. H. AU - Pollak, M. PY - 1998 DA - 1998// TI - Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study JO - Science VL - 279 UR - https://doi.org/10.1126/science.279.5350.563 DO - 10.1126/science.279.5350.563 ID - Chan1998 ER - TY - JOUR AU - Hankinson, S. E. AU - Willett, W. C. AU - Colditz, G. A. AU - Hunter, D. J. AU - Michaud, D. S. AU - Deroo, B. AU - Rosner, B. AU - Speizer, F. E. AU - Pollak, M. PY - 1998 DA - 1998// TI - Circulating concentrations of insulin-like growth factor I and risk of breast cancer JO - The Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(97)10384-1 DO - 10.1016/S0140-6736(97)10384-1 ID - Hankinson1998 ER - TY - JOUR AU - Wu, Y. AU - Yakar, S. AU - Zhao, L. AU - Hennighausen, L. AU - LeRoith, D. PY - 2002 DA - 2002// TI - Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis JO - Cancer Res VL - 62 ID - Wu2002 ER - TY - JOUR AU - Sandhu, M. S. AU - Dunger, D. B. AU - Giovannucci, E. L. PY - 2002 DA - 2002// TI - Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer JO - J Natl Cancer Inst VL - 94 UR - https://doi.org/10.1093/jnci/94.13.972 DO - 10.1093/jnci/94.13.972 ID - Sandhu2002 ER - TY - JOUR AU - Travis, R. C. AU - Appleby, P. N. AU - Martin, R. M. AU - Holly, J. M. AU - Albanes, D. AU - Black, A. AU - Bueno-de-Mesquita, H. B. AU - Chan, J. M. AU - Chen, C. AU - Chirlaque, M. -. D. PY - 2016 DA - 2016// TI - A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-1551 DO - 10.1158/0008-5472.CAN-15-1551 ID - Travis2016 ER - TY - JOUR AU - Tas, F. AU - Bilgin, E. AU - Tastekin, D. AU - Erturk, K. AU - Duranyildiz, D. PY - 2016 DA - 2016// TI - Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer JO - Biomedical reports VL - 4 ID - Tas2016 ER - TY - JOUR AU - Li, Y. AU - Zhang, J. AU - Zheng, C. AU - Zhu, H. AU - Yu, H. AU - Fan, L. PY - 2016 DA - 2016// TI - Circulating insulin-like growth factor-1 level and ovarian cancer risk JO - Cell Physiol Biochem VL - 38 UR - https://doi.org/10.1159/000438652 DO - 10.1159/000438652 ID - Li2016 ER - TY - JOUR AU - Bolton, K. A. AU - Avery-Kiejda, K. A. AU - Holliday, E. G. AU - Attia, J. AU - Bowden, N. A. AU - Scott, R. J. PY - 2016 DA - 2016// TI - A polymorphic repeat in the IGF1 promoter influences the risk of endometrial cancer JO - Endocr Connect VL - 5 UR - https://doi.org/10.1530/EC-16-0003 DO - 10.1530/EC-16-0003 ID - Bolton2016 ER - TY - JOUR AU - Sivakumar, R. AU - Koga, H. AU - Selvendiran, K. AU - Maeyama, M. AU - Ueno, T. AU - Sata, M. PY - 2009 DA - 2009// TI - Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition JO - Int J Oncol VL - 34 ID - Sivakumar2009 ER - TY - JOUR AU - Ouban, A. AU - Muraca, P. AU - Yeatman, T. AU - Coppola, D. PY - 2003 DA - 2003// TI - Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas JO - Hum Pathol VL - 34 UR - https://doi.org/10.1016/S0046-8177(03)00291-0 DO - 10.1016/S0046-8177(03)00291-0 ID - Ouban2003 ER - TY - JOUR AU - Shimizu, C. AU - Hasegawa, T. AU - Tani, Y. AU - Takahashi, F. AU - Takeuchi, M. AU - Watanabe, T. AU - Ando, M. AU - Katsumata, N. AU - Fujiwara, Y. PY - 2004 DA - 2004// TI - Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis JO - Hum Pathol VL - 35 UR - https://doi.org/10.1016/j.humpath.2004.09.005 DO - 10.1016/j.humpath.2004.09.005 ID - Shimizu2004 ER - TY - JOUR AU - Taliaferro-Smith, L. AU - Oberlick, E. AU - Liu, T. AU - McGlothen, T. AU - Alcaide, T. AU - Tobin, R. AU - Donnelly, S. AU - Commander, R. AU - Kline, E. AU - Nagaraju, G. P. PY - 2015 DA - 2015// TI - FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3023 DO - 10.18632/oncotarget.3023 ID - Taliaferro-Smith2015 ER - TY - JOUR AU - Ma, J. AU - Sawai, H. AU - Matsuo, Y. AU - Ochi, N. AU - Yasuda, A. AU - Takahashi, H. AU - Wakasugi, T. AU - Funahashi, H. AU - Sato, M. AU - Takeyama, H. PY - 2010 DA - 2010// TI - IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells JO - J Surg Res VL - 160 UR - https://doi.org/10.1016/j.jss.2008.08.016 DO - 10.1016/j.jss.2008.08.016 ID - Ma2010 ER - TY - JOUR AU - Pratsinis, H. AU - Kletsas, D. PY - 2007 DA - 2007// TI - PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways JO - Eur Spine J VL - 16 UR - https://doi.org/10.1007/s00586-007-0408-9 DO - 10.1007/s00586-007-0408-9 ID - Pratsinis2007 ER - TY - JOUR AU - Laviola, L. AU - Natalicchio, A. AU - Giorgino, F. PY - 2007 DA - 2007// TI - The IGF-I signaling pathway JO - Curr Pharm Des VL - 13 UR - https://doi.org/10.2174/138161207780249146 DO - 10.2174/138161207780249146 ID - Laviola2007 ER - TY - JOUR AU - Dupont, J. AU - Fernandez, A. M. AU - Glackin, C. A. AU - Helman, L. AU - LeRoith, D. PY - 2001 DA - 2001// TI - Insulin-like growth factor 1 (IGF-1)-induced twist expression is involved in the anti-apoptotic effects of the IGF-1 receptor JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M102664200 DO - 10.1074/jbc.M102664200 ID - Dupont2001 ER - TY - JOUR AU - Bachelder, R. E. AU - Yoon, S. -. O. AU - Franci, C. AU - Herreros, A. G. AU - Mercurio, A. M. PY - 2005 DA - 2005// TI - Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription implications for the epithelial–mesenchymal transition JO - J Cell Biol VL - 168 UR - https://doi.org/10.1083/jcb.200409067 DO - 10.1083/jcb.200409067 ID - Bachelder2005 ER - TY - JOUR AU - Ding, Q. AU - Xia, W. AU - Liu, J. -. C. AU - Yang, J. -. Y. AU - Lee, D. -. F. AU - Xia, J. AU - Bartholomeusz, G. AU - Li, Y. AU - Pan, Y. AU - Li, Z. PY - 2005 DA - 2005// TI - Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin JO - Mol Cell VL - 19 UR - https://doi.org/10.1016/j.molcel.2005.06.009 DO - 10.1016/j.molcel.2005.06.009 ID - Ding2005 ER - TY - JOUR AU - Park, B. -. C. AU - Kido, Y. AU - Accili, D. PY - 1999 DA - 1999// TI - Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes JO - Biochemistry VL - 38 UR - https://doi.org/10.1021/bi9830718 DO - 10.1021/bi9830718 ID - Park1999 ER - TY - JOUR AU - Kim, H. -. J. AU - Litzenburger, B. C. AU - Cui, X. AU - Delgado, D. A. AU - Grabiner, B. C. AU - Lin, X. AU - Lewis, M. T. AU - Gottardis, M. M. AU - Wong, T. W. AU - Attar, R. M. PY - 2007 DA - 2007// TI - Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-κB and snail JO - Mol Cell Biol VL - 27 UR - https://doi.org/10.1128/MCB.01315-06 DO - 10.1128/MCB.01315-06 ID - Kim2007 ER - TY - JOUR AU - Zhou, B. P. AU - Deng, J. AU - Xia, W. AU - Xu, J. AU - Li, Y. M. AU - Gunduz, M. AU - Hung, M. -. C. PY - 2004 DA - 2004// TI - Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition JO - Nat Cell Biol VL - 6 UR - https://doi.org/10.1038/ncb1173 DO - 10.1038/ncb1173 ID - Zhou2004 ER - TY - STD TI - Rota LM, Wood TL. Crosstalk of the insulin-like growth factor receptor with the Wnt signaling pathway in breast cancer. Front Endocrinol. 2015;6. ID - ref91 ER - TY - JOUR AU - Rota, L. M. AU - Albanito, L. AU - Shin, M. E. AU - Goyeneche, C. L. AU - Shushanov, S. AU - Gallagher, E. J. AU - LeRoith, D. AU - Lazzarino, D. A. AU - Wood, T. L. PY - 2014 DA - 2014// TI - IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0970 DO - 10.1158/0008-5472.CAN-14-0970 ID - Rota2014 ER - TY - JOUR AU - Kotiyal, S. AU - Bhattacharya, S. PY - 2014 DA - 2014// TI - Breast cancer stem cells, EMT and therapeutic targets JO - Biochem Biophys Res Commun VL - 453 UR - https://doi.org/10.1016/j.bbrc.2014.09.069 DO - 10.1016/j.bbrc.2014.09.069 ID - Kotiyal2014 ER - TY - JOUR AU - Playford, M. P. AU - Bicknell, D. AU - Bodmer, W. F. AU - Macaulay, V. M. PY - 2000 DA - 2000// TI - Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of β-catenin JO - Proc Natl Acad Sci VL - 97 UR - https://doi.org/10.1073/pnas.210394297 DO - 10.1073/pnas.210394297 ID - Playford2000 ER - TY - JOUR AU - Vanamala, J. AU - Reddivari, L. AU - Radhakrishnan, S. AU - Tarver, C. PY - 2010 DA - 2010// TI - Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-238 DO - 10.1186/1471-2407-10-238 ID - Vanamala2010 ER - TY - JOUR AU - Desbois-Mouthon, C. AU - Cadoret, A. AU - Blivet-Van Eggelpoel, M. -. J. AU - Bertrand, F. AU - Cherqui, G. AU - Perret, C. AU - Capeau, J. PY - 2001 DA - 2001// TI - Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation JO - Oncogene VL - 20 UR - https://doi.org/10.1038/sj.onc.1204064 DO - 10.1038/sj.onc.1204064 ID - Desbois-Mouthon2001 ER - TY - JOUR AU - Wang, Z. AU - Li, Y. AU - Kong, D. AU - H Sarkar, F. PY - 2010 DA - 2010// TI - The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness JO - Curr Drug Targets VL - 11 UR - https://doi.org/10.2174/138945010791170860 DO - 10.2174/138945010791170860 ID - Wang2010 ER - TY - JOUR AU - Noseda, M. AU - McLean, G. AU - Niessen, K. AU - Chang, L. AU - Pollet, I. AU - Montpetit, R. AU - Shahidi, R. AU - Dorovini-Zis, K. AU - Li, L. AU - Beckstead, B. PY - 2004 DA - 2004// TI - Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation JO - Circ Res VL - 94 UR - https://doi.org/10.1161/01.RES.0000124300.76171.C9 DO - 10.1161/01.RES.0000124300.76171.C9 ID - Noseda2004 ER - TY - JOUR AU - Timmerman, L. A. AU - Grego-Bessa, J. AU - Raya, A. AU - Bertrán, E. AU - Pérez-Pomares, J. M. AU - Díez, J. AU - Aranda, S. AU - Palomo, S. AU - McCormick, F. AU - Izpisúa-Belmonte, J. C. PY - 2004 DA - 2004// TI - Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation JO - Genes Dev VL - 18 UR - https://doi.org/10.1101/gad.276304 DO - 10.1101/gad.276304 ID - Timmerman2004 ER - TY - JOUR AU - Wang, Z. AU - Li, Y. AU - Banerjee, S. AU - Sarkar, F. H. PY - 2008 DA - 2008// TI - Exploitation of the Notch signaling pathway as a novel target for cancer therapy JO - Anticancer Res VL - 28 ID - Wang2008 ER - TY - JOUR AU - Wang, Z. AU - Kong, D. AU - Banerjee, S. AU - Li, Y. AU - Adsay, N. V. AU - Abbruzzese, J. AU - Sarkar, F. H. PY - 2007 DA - 2007// TI - Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-κB signaling JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2803 DO - 10.1158/0008-5472.CAN-07-2803 ID - Wang2007 ER - TY - JOUR AU - Eliasz, S. AU - Liang, S. AU - Chen, Y. AU - Marco, M. A. AU - Machek, O. AU - Skucha, S. AU - Miele, L. AU - Bocchetta, M. PY - 2010 DA - 2010// TI - Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.7 DO - 10.1038/onc.2010.7 ID - Eliasz2010 ER - TY - JOUR AU - Medyouf, H. AU - Gusscott, S. AU - Wang, H. AU - Tseng, J. -. C. AU - Wai, C. AU - Nemirovsky, O. AU - Trumpp, A. AU - Pflumio, F. AU - Carboni, J. AU - Gottardis, M. PY - 2011 DA - 2011// TI - High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling JO - J Exp Med VL - 208 UR - https://doi.org/10.1084/jem.20110121 DO - 10.1084/jem.20110121 ID - Medyouf2011 ER - TY - JOUR AU - Malaguarnera, R. AU - Belfiore, A. PY - 2014 DA - 2014// TI - The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells JO - Front Endocrinol VL - 5 UR - https://doi.org/10.3389/fendo.2014.00010 DO - 10.3389/fendo.2014.00010 ID - Malaguarnera2014 ER - TY - JOUR AU - Rao, G. AU - Pedone, C. A. AU - Valle, L. AU - Reiss, K. AU - Holland, E. C. AU - Fults, D. W. PY - 2004 DA - 2004// TI - Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1207818 DO - 10.1038/sj.onc.1207818 ID - Rao2004 ER - TY - JOUR AU - Ma’in, Y. M. AU - Ali, S. AU - Ahmad, A. AU - Gadgeel, S. AU - Sarkar, F. H. PY - 2011 DA - 2011// TI - Up-regulation of sonic hedgehog contributes to TGF-β1-induced epithelial to mesenchymal transition in NSCLC cells JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0016068 DO - 10.1371/journal.pone.0016068 ID - Ma’in2011 ER - TY - JOUR AU - Weroha, S. J. AU - Haluska, P. PY - 2008 DA - 2008// TI - IGF-1 receptor inhibitors in clinical trials—early lessons JO - J Mammary Gland Biol Neoplasia VL - 13 UR - https://doi.org/10.1007/s10911-008-9104-6 DO - 10.1007/s10911-008-9104-6 ID - Weroha2008 ER - TY - JOUR AU - Garcı́a-Echeverrı́a, C. AU - Pearson, M. A. AU - Marti, A. AU - Meyer, T. AU - Mestan, J. AU - Zimmermann, J. AU - Gao, J. AU - Brueggen, J. AU - Capraro, H. -. G. AU - Cozens, R. PY - 2004 DA - 2004// TI - In vivo antitumor activity of NVP-AEW541—a novel, potent, and selective inhibitor of the IGF-IR kinase JO - Cancer Cell VL - 5 UR - https://doi.org/10.1016/S1535-6108(04)00051-0 DO - 10.1016/S1535-6108(04)00051-0 ID - Garcı́a-Echeverrı́a2004 ER - TY - JOUR AU - Gualberto, A. AU - Pollak, M. PY - 2009 DA - 2009// TI - Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2009.172 DO - 10.1038/onc.2009.172 ID - Gualberto2009 ER - TY - JOUR AU - Buck, E. AU - Mulvihill, M. PY - 2011 DA - 2011// TI - Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer JO - Expert Opin Investig Drugs VL - 20 UR - https://doi.org/10.1517/13543784.2011.558501 DO - 10.1517/13543784.2011.558501 ID - Buck2011 ER - TY - JOUR AU - Gombos, A. AU - Metzger-Filho, O. AU - Dal Lago, L. AU - Awada-Hussein, A. PY - 2012 DA - 2012// TI - Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad? JO - Invest New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-012-9811-0 DO - 10.1007/s10637-012-9811-0 ID - Gombos2012 ER - TY - JOUR AU - Rodon, J. AU - DeSantos, V. AU - Ferry, R. J. AU - Kurzrock, R. PY - 2008 DA - 2008// TI - Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0265 DO - 10.1158/1535-7163.MCT-08-0265 ID - Rodon2008 ER - TY - JOUR AU - Abou-Alfa, G. K. AU - Capanu, M. AU - O’Reilly, E. M. AU - Ma, J. AU - Chou, J. F. AU - Gansukh, B. AU - Shia, J. AU - Kalin, M. AU - Katz, S. AU - Abad, L. PY - 2014 DA - 2014// TI - A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinoma JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2013.09.008 DO - 10.1016/j.jhep.2013.09.008 ID - Abou-Alfa2014 ER - TY - JOUR AU - Gradishar, W. J. AU - Yardley, D. A. AU - Layman, R. AU - Sparano, J. A. AU - Chuang, E. AU - Northfelt, D. W. AU - Schwartz, G. N. AU - Youssoufian, H. AU - Tang, S. AU - Novosiadly, R. PY - 2016 DA - 2016// TI - Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-0588 DO - 10.1158/1078-0432.CCR-15-0588 ID - Gradishar2016 ER - TY - JOUR AU - Philip, P. A. AU - Goldman, B. AU - Ramanathan, R. K. AU - Lenz, H. J. AU - Lowy, A. M. AU - Whitehead, R. P. AU - Wakatsuki, T. AU - Iqbal, S. AU - Gaur, R. AU - Benedetti, J. K. PY - 2014 DA - 2014// TI - Dual blockade of epidermal growth factor receptor and insulin‐like growth factor receptor–1 signaling in metastatic pancreatic cancer: Phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib (SWOG S0727) JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28744 DO - 10.1002/cncr.28744 ID - Philip2014 ER - TY - CHAP AU - Jassem, J. AU - Langer, C. AU - Karp, D. AU - Mok, T. AU - Benner, R. AU - Green, S. AU - Park, K. AU - Novello, S. AU - Strausz, J. AU - Gualberto, A. PY - 2010 DA - 2010// TI - Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) BT - ASCO annual meeting proceedings ID - Jassem2010 ER - TY - JOUR AU - Higano, C. S. AU - Berlin, J. AU - Gordon, M. AU - LoRusso, P. AU - Tang, S. AU - Dontabhaktuni, A. AU - Schwartz, J. AU - Cosaert, J. AU - Mehnert, J. PY - 2015 DA - 2015// TI - Safety, tolerability, and pharmacokinetics of single and multiple doses of intravenous cixutumumab (IMC-A12), an inhibitor of the insulin-like growth factor-I receptor, administered weekly or every 2 weeks in patients with advanced solid tumors JO - Invest New Drugs VL - 33 UR - https://doi.org/10.1007/s10637-015-0217-7 DO - 10.1007/s10637-015-0217-7 ID - Higano2015 ER - TY - STD TI - Langer CJ, Novello S, Park K, Krzakowski M, Karp DD, Mok T, Benner RJ, Scranton JR, Olszanski AJ, Jassem J. Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non–small-cell lung cancer. J Clin Oncol. 2014;32(19):2059–66. ID - ref118 ER - TY - JOUR AU - Garofalo, C. AU - Manara, M. AU - Nicoletti, G. AU - Marino, M. AU - Lollini, P. AU - Astolfi, A. AU - Pandini, G. AU - Lopez-Guerrero, J. AU - Schaefer, K. AU - Belfiore, A. PY - 2011 DA - 2011// TI - Efficacy of and resistance to anti-IGF-1R therapies in Ewing’s sarcoma is dependent on insulin receptor signaling JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.640 DO - 10.1038/onc.2010.640 ID - Garofalo2011 ER - TY - JOUR AU - Ulanet, D. B. AU - Ludwig, D. L. AU - Kahn, C. R. AU - Hanahan, D. PY - 2010 DA - 2010// TI - Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy JO - Proc Natl Acad Sci VL - 107 UR - https://doi.org/10.1073/pnas.0914076107 DO - 10.1073/pnas.0914076107 ID - Ulanet2010 ER - TY - STD TI - Křížková K, Chrudinová M, Povalová A, Selicharová I, Collinsová M, Vanek V, Brzozowski AM, Jiracek J, Zakova L. The insulin-IGF hybrids as molecular probes of hormone: receptor binding specificity. Biochemistry. 2016. ID - ref121 ER - TY - STD TI - Vigneri R, Goldfine I, Frittitta L. Insulin, insulin receptors, and cancer. J Endocrinol Invest. 2016;39(12):1365–76. ID - ref122 ER - TY - JOUR AU - Nahta, R. AU - Yuan, L. X. AU - Zhang, B. AU - Kobayashi, R. AU - Esteva, F. J. PY - 2005 DA - 2005// TI - Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3841 DO - 10.1158/0008-5472.CAN-04-3841 ID - Nahta2005 ER - TY - JOUR AU - Haluska, P. AU - Carboni, J. M. AU - TenEyck, C. AU - Attar, R. M. AU - Hou, X. AU - Yu, C. AU - Sagar, M. AU - Wong, T. W. AU - Gottardis, M. M. AU - Erlichman, C. PY - 2008 DA - 2008// TI - HER receptor signaling confers resistance to the insulin-like growth factor-I receptor inhibitor, BMS-536924 JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0493 DO - 10.1158/1535-7163.MCT-08-0493 ID - Haluska2008 ER - TY - JOUR AU - Huang, F. AU - Greer, A. AU - Hurlburt, W. AU - Han, X. AU - Hafezi, R. AU - Wittenberg, G. M. AU - Reeves, K. AU - Chen, J. AU - Robinson, D. AU - Li, A. PY - 2009 DA - 2009// TI - The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-0835 DO - 10.1158/0008-5472.CAN-08-0835 ID - Huang2009 ER - TY - JOUR AU - Barnes, C. J. AU - Ohshiro, K. AU - Rayala, S. K. AU - El-Naggar, A. K. AU - Kumar, R. PY - 2007 DA - 2007// TI - Insulin-like growth factor receptor as a therapeutic target in head and neck cancer JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2040 DO - 10.1158/1078-0432.CCR-06-2040 ID - Barnes2007 ER - TY - JOUR AU - Buck, E. AU - Eyzaguirre, A. AU - Thomson, S. AU - Mulvihill, M. AU - Barr, S. AU - Brown, E. AU - O’Connor, M. AU - Yao, Y. AU - Pachter, J. AU - Miglarese, M. PY - 2008 DA - 2008// TI - Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6720 DO - 10.1158/0008-5472.CAN-07-6720 ID - Buck2008 ER - TY - JOUR AU - Atzori, F. AU - Tabernero, J. AU - Cervantes, A. AU - Prudkin, L. AU - Andreu, J. AU - Rodríguez-Braun, E. AU - Domingo, A. AU - Guijarro, J. AU - Gamez, C. AU - Rodon, J. PY - 2011 DA - 2011// TI - A phase I pharmacokinetic and pharmacodynamic study of dalotuzumab (MK-0646), an anti-insulin-like growth factor-1 receptor monoclonal antibody, in patients with advanced solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-3336 DO - 10.1158/1078-0432.CCR-10-3336 ID - Atzori2011 ER - TY - JOUR AU - Kurzrock, R. AU - Patnaik, A. AU - Aisner, J. AU - Warren, T. AU - Leong, S. AU - Benjamin, R. AU - Eckhardt, S. G. AU - Eid, J. E. AU - Greig, G. AU - Habben, K. PY - 2010 DA - 2010// TI - A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-3220 DO - 10.1158/1078-0432.CCR-09-3220 ID - Kurzrock2010 ER - TY - JOUR AU - Schwartz, G. K. AU - Tap, W. D. AU - Qin, L. -. X. AU - Livingston, M. B. AU - Undevia, S. D. AU - Chmielowski, B. AU - Agulnik, M. AU - Schuetze, S. M. AU - Reed, D. R. AU - Okuno, S. H. PY - 2013 DA - 2013// TI - Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70049-4 DO - 10.1016/S1470-2045(13)70049-4 ID - Schwartz2013 ER - TY - JOUR AU - Beckwith, H. AU - Yee, D. PY - 2015 DA - 2015// TI - Minireview: were the IGF signaling inhibitors All Bad? JO - Mol Endocrinol VL - 29 UR - https://doi.org/10.1210/me.2015-1157 DO - 10.1210/me.2015-1157 ID - Beckwith2015 ER - TY - JOUR AU - Cao, Y. AU - Roth, M. AU - Piperdi, S. AU - Montoya, K. AU - Sowers, R. AU - Rao, P. AU - Geller, D. AU - Houghton, P. AU - Kolb, E. A. AU - Gill, J. PY - 2014 DA - 2014// TI - Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0106249 DO - 10.1371/journal.pone.0106249 ID - Cao2014 ER - TY - JOUR AU - Fuchs, C. S. AU - Azevedo, S. AU - Okusaka, T. AU - Laethem, J. -. L. AU - Lipton, L. AU - Riess, H. AU - Szczylik, C. AU - Moore, M. AU - Peeters, M. AU - Bodoky, G. PY - 2015 DA - 2015// TI - A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv027 DO - 10.1093/annonc/mdv027 ID - Fuchs2015 ER - TY - CHAP AU - Watkins, D. J. AU - Ayers, M. AU - Cunningham, D. AU - Tabernero, J. AU - Tejpar, S. AU - Kim, T. -. Y. AU - Kim, T. W. AU - Kim, S. Y. AU - Roh, J. K. AU - Beale, P. J. PY - 2012 DA - 2012// TI - Molecular analysis of the randomized phase II/III study of the anti-IGF-1R antibody dalotuzumab (MK-0646) in combination with cetuximab (Cx) and irinotecan (Ir) in the treatment of chemorefractory KRAS wild-type metastatic colorectal cancer (mCRC) BT - ASCO annual meeting proceedings ID - Watkins2012 ER - TY - JOUR AU - Mohapatra, B. AU - Ahmad, G. AU - Nadeau, S. AU - Zutshi, N. AU - An, W. AU - Scheffe, S. AU - Dong, L. AU - Feng, D. AU - Goetz, B. AU - Arya, P. PY - 2013 DA - 2013// TI - Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases. Biochimica et Biophysica Acta (BBA)-Molecular JO - Cell Res VL - 1833 ID - Mohapatra2013 ER - TY - JOUR AU - Fang, D. AU - Wang, H. -. Y. AU - Fang, N. AU - Altman, Y. AU - Elly, C. AU - Liu, Y. -. C. PY - 2001 DA - 2001// TI - Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M008901200 DO - 10.1074/jbc.M008901200 ID - Fang2001 ER - TY - JOUR AU - Caligiuri, M. A. AU - Briesewitz, R. AU - Yu, J. AU - Wang, L. AU - Wei, M. AU - Arnoczky, K. J. AU - Marburger, T. B. AU - Wen, J. AU - Perrotti, D. AU - Bloomfield, C. D. PY - 2007 DA - 2007// TI - Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2006-12-061176 DO - 10.1182/blood-2006-12-061176 ID - Caligiuri2007 ER - TY - JOUR AU - Xu, L. AU - Zhang, Y. AU - Liu, J. AU - Qu, J. AU - Hu, X. AU - Zhang, F. AU - Zheng, H. AU - Qu, X. AU - Liu, Y. PY - 2012 DA - 2012// TI - TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.03.005 DO - 10.1016/j.ejca.2012.03.005 ID - Xu2012 ER - TY - JOUR AU - Zhang, L. AU - Teng, Y. AU - Fan, Y. AU - Wang, Y. AU - Li, W. AU - Shi, J. AU - Ma, Y. AU - Li, C. AU - Shi, X. AU - Qu, X. PY - 2015 DA - 2015// TI - The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4382 DO - 10.18632/oncotarget.4382 ID - Zhang2015 ER - TY - JOUR AU - Sorokin, A. AU - Chen, J. PY - 2013 DA - 2013// TI - MEMO1, a new IRS1-interacting protein, induces epithelial–mesenchymal transition in mammary epithelial cells JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.327 DO - 10.1038/onc.2012.327 ID - Sorokin2013 ER - TY - JOUR AU - Zhang, Y. AU - Pan, Q. AU - Zhong, H. AU - Merajver, S. D. AU - Kleer, C. G. PY - 2005 DA - 2005// TI - Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells JO - Breast Cancer Res VL - 7 UR - https://doi.org/10.1186/bcr1351 DO - 10.1186/bcr1351 ID - Zhang2005 ER - TY - JOUR AU - Kleer, C. G. AU - Zhang, Y. AU - Merajver, S. D. PY - 2007 DA - 2007// TI - CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer JO - Cells Tissues Organs VL - 185 UR - https://doi.org/10.1159/000101308 DO - 10.1159/000101308 ID - Kleer2007 ER - TY - JOUR AU - Buck, E. AU - Gokhale, P. C. AU - Koujak, S. AU - Brown, E. AU - Eyzaguirre, A. AU - Tao, N. AU - Lerner, L. AU - Chiu, M. I. AU - Wild, R. AU - Epstein, D. PY - 2010 DA - 2010// TI - Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-10-0318 DO - 10.1158/1535-7163.MCT-10-0318 ID - Buck2010 ER - TY - JOUR AU - Liao, G. AU - Wang, M. AU - Ou, Y. AU - Zhao, Y. PY - 2014 DA - 2014// TI - IGF-1-induced epithelial–mesenchymal transition in MCF-7 cells is mediated by MUC1 JO - Cell Signal VL - 26 UR - https://doi.org/10.1016/j.cellsig.2014.06.004 DO - 10.1016/j.cellsig.2014.06.004 ID - Liao2014 ER - TY - JOUR AU - Li, C. AU - Li, J. AU - Wu, D. AU - Han, G. PY - 2016 DA - 2016// TI - The involvement of survivin in insulin-like growth factor 1-induced epithelial-mesenchymal transition in gastric cancer JO - Tumor Biology VL - 37 UR - https://doi.org/10.1007/s13277-015-3909-x DO - 10.1007/s13277-015-3909-x ID - Li2016 ER - TY - JOUR AU - Zhao, X. AU - Dou, W. AU - He, L. AU - Liang, S. AU - Tie, J. AU - Liu, C. AU - Li, T. AU - Lu, Y. AU - Mo, P. AU - Shi, Y. PY - 2013 DA - 2013// TI - MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.156 DO - 10.1038/onc.2012.156 ID - Zhao2013 ER - TY - JOUR AU - Schwartz, G. K. AU - Dickson, M. A. AU - LoRusso, P. M. AU - Sausville, E. A. AU - Maekawa, Y. AU - Watanabe, Y. AU - Kashima, N. AU - Nakashima, D. AU - Akinaga, S. PY - 2016 DA - 2016// TI - Preclinical and first‐in‐human phase I studies of KW‐2450, an oral tyrosine kinase inhibitor with insulin‐like growth factor receptor‐1/insulin receptor selectivity JO - Cancer Sci VL - 107 UR - https://doi.org/10.1111/cas.12906 DO - 10.1111/cas.12906 ID - Schwartz2016 ER - TY - JOUR AU - Huang, F. AU - Chang, H. AU - Greer, A. AU - Hillerman, S. AU - Reeves, K. A. AU - Hurlburt, W. AU - Cogswell, J. AU - Patel, D. AU - Qi, Z. AU - Fairchild, C. PY - 2015 DA - 2015// TI - IRS2 copy number gain, KRAS and BRAF mutation status as predictive biomarkers for response to the IGF-1R/IR inhibitor BMS-754807 in colorectal cancer cell lines JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0794-T DO - 10.1158/1535-7163.MCT-14-0794-T ID - Huang2015 ER - TY - JOUR AU - Fassnacht, M. AU - Berruti, A. AU - Baudin, E. AU - Demeure, M. J. AU - Gilbert, J. AU - Haak, H. AU - Kroiss, M. AU - Quinn, D. I. AU - Hesseltine, E. AU - Ronchi, C. L. PY - 2015 DA - 2015// TI - Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70081-1 DO - 10.1016/S1470-2045(15)70081-1 ID - Fassnacht2015 ER - TY - JOUR AU - Siddle, K. PY - 2012 DA - 2012// TI - Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances JO - Front Endocrinol VL - 3 UR - https://doi.org/10.3389/fendo.2012.00034 DO - 10.3389/fendo.2012.00034 ID - Siddle2012 ER - TY - JOUR AU - Argetsinger, L. S. AU - Hsu, G. W. AU - Myers, M. G. AU - Billestrup, N. AU - White, M. F. AU - Carter-Su, C. PY - 1995 DA - 1995// TI - Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1 JO - J. Biol. Chem. VL - 270 UR - https://doi.org/10.1074/jbc.270.24.14685 DO - 10.1074/jbc.270.24.14685 ID - Argetsinger1995 ER - TY - JOUR AU - Geng, Y. AU - Ju, Y. AU - Ren, F. AU - Qiu, Y. AU - Tomita, Y. AU - Tomoeda, M. AU - Kishida, M. AU - Wang, Y. AU - Jin, L. AU - Su, F. PY - 2014 DA - 2014// TI - Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-catenin signaling through blocking autophagic degradation of dishevelled2 JO - J. Biol. Chem. VL - 289 UR - https://doi.org/10.1074/jbc.M113.544999 DO - 10.1074/jbc.M113.544999 ID - Geng2014 ER - TY - JOUR AU - Zha, J. AU - O’Brien, C. AU - Savage, H. AU - Huw, L. -. Y. AU - Zhong, F. AU - Berry, L. AU - Phillips, G. D. L. AU - Luis, E. AU - Cavet, G. AU - Hu, X. PY - 2009 DA - 2009// TI - Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-09-0381 DO - 10.1158/1535-7163.MCT-09-0381 ID - Zha2009 ER - TY - JOUR AU - Mukohara, T. AU - Shimada, H. AU - Ogasawara, N. AU - Wanikawa, R. AU - Shimomura, M. AU - Nakatsura, T. AU - Ishii, G. AU - Park, J. O. AU - Jänne, P. A. AU - Saijo, N. PY - 2009 DA - 2009// TI - Sensitivity of breast cancer cell lines to the novel insulin-like growth factor-1 receptor (IGF-1R) inhibitor NVP-AEW541 is dependent on the level of IRS-1 expression JO - Cancer Lett VL - 282 UR - https://doi.org/10.1016/j.canlet.2009.02.056 DO - 10.1016/j.canlet.2009.02.056 ID - Mukohara2009 ER - TY - STD TI - de Lint K, Poell JB, Soueidan H, Jastrzebski K, Rodriguez JV, Lieftink C, Wessels LF, Beijersbergen RL. Sensitizing triple-negative breast cancer to PI3K inhibition by co-targeting IGF1R. Mol Cancer Ther. 2016;15(7):1545–56. ID - ref155 ER - TY - JOUR AU - Shi, Y. AU - Yan, H. AU - Frost, P. AU - Gera, J. AU - Lichtenstein, A. PY - 2005 DA - 2005// TI - Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade JO - Mol Cancer Ther VL - 4 UR - https://doi.org/10.1158/1535-7163.MCT-05-0068 DO - 10.1158/1535-7163.MCT-05-0068 ID - Shi2005 ER - TY - JOUR AU - Naing, A. AU - Lorusso, P. AU - Fu, S. AU - Hong, D. AU - Chen, H. AU - Doyle, L. AU - Phan, A. T. AU - Habra, M. AU - Kurzrock, R. PY - 2013 DA - 2013// TI - Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma JO - Br J Cancer VL - 108 UR - https://doi.org/10.1038/bjc.2013.46 DO - 10.1038/bjc.2013.46 ID - Naing2013 ER - TY - JOUR AU - Cosaceanu, D. AU - Budiu, R. AU - Carapancea, M. AU - Castro, J. AU - Lewensohn, R. AU - Dricu, A. PY - 2007 DA - 2007// TI - Ionizing radiation activates IGF-1R triggering a cytoprotective signaling by interfering with Ku-DNA binding and by modulating Ku86 expression via a p38 kinase-dependent mechanism JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210037 DO - 10.1038/sj.onc.1210037 ID - Cosaceanu2007 ER - TY - JOUR AU - Iwasa, T. AU - Okamoto, I. AU - Suzuki, M. AU - Hatashita, E. AU - Yamada, Y. AU - Fukuoka, M. AU - Ono, K. AU - Nakagawa, K. PY - 2009 DA - 2009// TI - Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non–small cell lung cancer cells JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0478 DO - 10.1158/1078-0432.CCR-09-0478 ID - Iwasa2009 ER - TY - JOUR AU - Wang, Y. -. H. AU - Wang, Z. -. X. AU - Qiu, Y. AU - Xiong, J. AU - Chen, Y. -. X. AU - Miao, D. -. S. AU - De, W. PY - 2009 DA - 2009// TI - Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells JO - Mol Cell Biochem VL - 327 UR - https://doi.org/10.1007/s11010-009-0064-y DO - 10.1007/s11010-009-0064-y ID - Wang2009 ER - TY - JOUR AU - Ramcharan, R. N. AU - Aleksic, T. AU - Gao, S. AU - Tanner, J. AU - Darvill, N. AU - Bridges, E. AU - Asher, R. AU - Watson, A. J. AU - Margison, G. P. AU - Repapi, E. PY - 2014 DA - 2014// TI - Inhibition of type 1 insulin-like growth factor receptor (IGF-1R) influences processing of replication-associated DNA double-strand breaks (DSBs) and induces schedule-dependent sensitization of human melanoma to temozolomide (TMZ) JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/1538-7445.AM2014-1741 DO - 10.1158/1538-7445.AM2014-1741 ID - Ramcharan2014 ER - TY - JOUR AU - Singh, R. K. AU - Gaikwad, S. M. AU - Jinager, A. AU - Chaudhury, S. AU - Maheshwari, A. AU - Ray, P. PY - 2014 DA - 2014// TI - IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells JO - Cancer Lett VL - 354 UR - https://doi.org/10.1016/j.canlet.2014.08.023 DO - 10.1016/j.canlet.2014.08.023 ID - Singh2014 ER - TY - JOUR AU - Mani, S. A. AU - Guo, W. AU - Liao, M. -. J. AU - Eaton, E. N. AU - Ayyanan, A. AU - Zhou, A. Y. AU - Brooks, M. AU - Reinhard, F. AU - Zhang, C. C. AU - Shipitsin, M. PY - 2008 DA - 2008// TI - The epithelial-mesenchymal transition generates cells with properties of stem cells JO - Cell VL - 133 UR - https://doi.org/10.1016/j.cell.2008.03.027 DO - 10.1016/j.cell.2008.03.027 ID - Mani2008 ER - TY - JOUR AU - Polyak, K. AU - Weinberg, R. A. PY - 2009 DA - 2009// TI - Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2620 DO - 10.1038/nrc2620 ID - Polyak2009 ER - TY - JOUR AU - Fang, X. AU - Cai, Y. AU - Liu, J. AU - Wang, Z. AU - Wu, Q. AU - Zhang, Z. AU - Yang, C. AU - Yuan, L. AU - Ouyang, G. PY - 2011 DA - 2011// TI - Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2011.181 DO - 10.1038/onc.2011.181 ID - Fang2011 ER - TY - JOUR AU - Al-Hajj, M. AU - Wicha, M. S. AU - Benito-Hernandez, A. AU - Morrison, S. J. AU - Clarke, M. F. PY - 2003 DA - 2003// TI - Prospective identification of tumorigenic breast cancer cells JO - Proc Natl Acad Sci VL - 100 UR - https://doi.org/10.1073/pnas.0530291100 DO - 10.1073/pnas.0530291100 ID - Al-Hajj2003 ER - TY - JOUR AU - Kurrey, N. K. AU - Jalgaonkar, S. P. AU - Joglekar, A. V. AU - Ghanate, A. D. AU - Chaskar, P. D. AU - Doiphode, R. Y. AU - Bapat, S. A. PY - 2009 DA - 2009// TI - Snail and slug mediate radioresistance and chemoresistance by antagonizing p53‐mediated apoptosis and acquiring a stem‐like phenotype in ovarian cancer cells JO - Stem Cells VL - 27 UR - https://doi.org/10.1002/stem.154 DO - 10.1002/stem.154 ID - Kurrey2009 ER - TY - JOUR AU - Hwang, W. L. AU - Yang, M. H. AU - Tsai, M. L. AU - Lan, H. Y. AU - Su, S. H. AU - Chang, S. C. AU - Teng, H. W. AU - Yang, S. H. AU - Lan, Y. T. AU - Chiou, S. H. PY - 2011 DA - 2011// TI - SNAIL regulates interleukin-8 expression, stem cell–like activity, and tumorigenicity of human colorectal carcinoma cells JO - Gastroenterology VL - 141 UR - https://doi.org/10.1053/j.gastro.2011.04.008 DO - 10.1053/j.gastro.2011.04.008 ID - Hwang2011 ER - TY - JOUR AU - Chang, W. -. W. AU - Lin, R. -. J. AU - Yu, J. AU - Chang, W. -. Y. AU - Fu, C. -. H. AU - Lai, A. C. -. Y. AU - Yu, J. -. C. AU - Alice, L. Y. PY - 2013 DA - 2013// TI - The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors JO - Breast Cancer Res VL - 15 UR - https://doi.org/10.1186/bcr3423 DO - 10.1186/bcr3423 ID - Chang2013 ER - TY - JOUR AU - Dallas, N. A. AU - Xia, L. AU - Fan, F. AU - Gray, M. J. AU - Gaur, P. AU - Buren, G. AU - Samuel, S. AU - Kim, M. P. AU - Lim, S. J. AU - Ellis, L. M. PY - 2009 DA - 2009// TI - Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-08-2023 DO - 10.1158/0008-5472.CAN-08-2023 ID - Dallas2009 ER - TY - STD TI - Yao C, Su L, Shan J, Zhu C, Liu L, Liu C, Xu Y, Yang Z, Bian X, Shao J. IGF/STAT3/NANOG/Slug signaling axis simultaneously controls epithelial‐mesenchymal transition and stemness maintenance in colorectal cancer. STEM CELLS. 2016. ID - ref171 ER - TY - JOUR AU - Shan, J. AU - Shen, J. AU - Liu, L. AU - Xia, F. AU - Xu, C. AU - Duan, G. AU - Xu, Y. AU - Ma, Q. AU - Yang, Z. AU - Zhang, Q. PY - 2012 DA - 2012// TI - Nanog regulates self‐renewal of cancer stem cells through the insulin‐like growth factor pathway in human hepatocellular carcinoma JO - Hepatology VL - 56 UR - https://doi.org/10.1002/hep.25745 DO - 10.1002/hep.25745 ID - Shan2012 ER -